Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO Trial
Institute Rotary Cancer Hospital, New Delhi, India
University of Maryland

      The aim of the study is to test whether a resource-sparing 4-week, 20-fraction course of
      accelerated hypofractionated radiotherapy is non-inferior to accelerated radiotherapy
      delivering 33 fractions over 5.5 weeks in the treatment of patients with Stage I-IV squamous
      cell carcinoma of the pharynx, larynx and oral cavity with the exception of paranasal sinus,
      nasopharyngeal and stage I-II glottic carcinomas.
    
Radiation